These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2501273)

  • 41. An in vitro investigation of the intraphagocytic bioactivity of difloxacin, ciprofloxacin, pefloxacin and fleroxacin.
    van Rensburg CE; Joone G; Anderson R
    Chemotherapy; 1989; 35(4):273-7. PubMed ID: 2504545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone.
    Aoyama H; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():99-114. PubMed ID: 2849604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fleroxacin (Ro 23-6240) in the treatment of gonorrhoea.
    Boerema JB; Moesker HL; Notowicz ; Van de Rhee HJ
    J Antimicrob Chemother; 1988 Jan; 21(1):140-1. PubMed ID: 3128518
    [No Abstract]   [Full Text] [Related]  

  • 44. Renal tolerance of fleroxacin in healthy volunteers.
    Mondorf AW; Buch A; Steinbacher G; Rüdel C; Falkenberg FW
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():179-89. PubMed ID: 2904925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria.
    Salfinger M; Hohl P; Kafader FM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():55-63. PubMed ID: 3144550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In-vitro activity of fleroxacin compared with three other quinolones.
    Bremner DA; Dickie AS; Singh KP
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():43-7. PubMed ID: 3144548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fleroxacin in the treatment of uncomplicated acute cystitis in women.
    Møller BR; Kaspersen P; Mamsen A; Korsager B; Quitzau K
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():215-8. PubMed ID: 3144540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
    Lewin CS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue.
    Daschner FD; Petersen EE; Just HM; Hillemanns HG
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():247-9. PubMed ID: 6352627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
    Leibovitz E; Keren G; Shabtai M; Barzilai A; Rubinstein E
    J Antimicrob Chemother; 1989 Sep; 24(3):375-85. PubMed ID: 2509411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
    Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fleroxacin, a long acting fluoroquinolone with broad spectrum activity. International Congress of Chemotherapy. Istanbul, Turkey, 19-24 July 1987. Proceedings.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():1-234. PubMed ID: 3144527
    [No Abstract]   [Full Text] [Related]  

  • 55. High-performance liquid chromatographic assay and erythrocyte partitioning of fleroxacin, a new fluoroquinolone antibiotic.
    Brunt E; Limberg J; Derendorf H
    J Pharm Biomed Anal; 1990; 8(1):67-71. PubMed ID: 2129330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An assessment of cerebral blood flow and metabolism after fleroxacin therapy.
    Gardner SF; Green JA; Bednarczyk EM; Nelson AD; Leisure G; Miraldi F
    J Clin Pharmacol; 1991 Feb; 31(2):151-7. PubMed ID: 1901321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A study on the treatment duration of an antibacterial agent in complicated urinary tract infections. Utility and recurrence after 14-day treatment by fleroxacin].
    Arakawa S; Takagi S; Matsumoto O; Kamidono S; Sengoku A; Hazama M; Yamazaki H; Hamami G; Okamoto Y; Tanaka H
    Jpn J Antibiot; 1991 Jul; 44(7):718-31. PubMed ID: 1909383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative studies of fleroxacin and ofloxacin in experimental pyelonephritis.
    Ritzerfeld W
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():119-22. PubMed ID: 3144529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis.
    Pust RA; Ackenheil-Köppe HR; Weidner W; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():227-30. PubMed ID: 3144543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic data in gynecological surgery using preoperative augmentin.
    Von Kobyletzki V
    Chemioterapia; 1987 Jun; 6(2 Suppl):262-4. PubMed ID: 3509406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.